Skip to main content

Table 3 Summary of prediction improvement assessments comparing models with and without hematuria for halving of eGFR, ESRD and death

From: Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

 

C-statistics

Three categories NRI (95%CI)

Category-Free NRI (95%CI)

Hematuria

Increase

Events

Non-events

Overall

Events

Non-events

Overall

No

Yes

       

Halving of eGFR/ESRDa

0.897

0.898

0.001

−0.01 (−0.04 to 0.02)

0.01 (−0.01 to 0.02)

0.00 (−0.04 to 0.03)

0.29 (0.18 to 0.41)

0.35 (0.23 to 0.47)

0.64 (0.44 to 0.84)

ESRDb

0.929

0.931

0.002

0.01 (−0.04 to 0.05)

0.01 (−0.01 to 0.02)

0.01 (−0.03 to 0.06)

0.41 (0.28 to 0.55)

0.22 (0.01 to 0.42)

0.63 (0.35 to 0.91)

Deathc

0.770

0.782

0.012

0 (−0.10 to 0.10)

0.01 (−0.02 to 0.04)

0.01 (− 0.10 to 0.12)

0.04 (− 0.14 to 0.22)

0.38 (0.33 to 0.43)

0.42 (0.22 to 0.62)

  1. Halving of eGFR or ESRD: model includes: age, race, sex, eGFR, albuminuria, diabetes, systolic blood pressure, BMI, waist circumference, NT-pro-BNP, serum albumin. ESRD: model includes age, sex, eGFR, albuminuria, diabetes, waist circumference, NT-pro-BNP, FGF-23, Calcium, iPTH, serum albumin, uric acid, triglycerides. Death: model includes BMI, history of CVD, High-sensitive Troponin T, NT-pro-BNP, high sensitivity CRP, use of ACE/ARBs. Categories of predicted probability of the outcome used in the three category NRI: 0 to 10%; > 10 to 15%; > = 15% for halving of eGFR/ESRD; 0 to 5%; > 5 to 10%; > = 10% for ESRD; 0 to 3%; > 3 to 8%; > = 8% for death
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us